Skip to main content
Premium Trial:

Request an Annual Quote

University of Florida Breaks Ground on $45M Translational Research Building

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Florida has broken ground on construction of a 120,000-square-foot institute that will house research into aging and clinical and translational studies, including genomics and bioinformatics.

The bi-winged Clinical and Translational Research Building (CTRB) will include a 40,000-square-foot wing that will be the new home of UF's Institute on Aging, and 80,000 square feet will be dedicated to a Clinical and Translational Science Institute (CTSI) and other research programs, conference, training, and reception areas.

The new building was funded with $45 million, including a $15 million grant from the National Institutes of Health under the American Recovery and Reinvestment Act for the Institute on Aging wing, and $30 million from the University to pay for the CTSI and the building's other features.

"The CTRB will be the home of patient-centered innovation and discoveries that help secure a healthy future for the citizens of Florida and the nation," David Guzick, senior vice president for health affairs and president of the UF & Shands Health System, said in a statement.

"One of our most important jobs as a major research institution is to streamline the process of getting medical discoveries from the lab to the hospital or doctor's office," added UF President Bernie Machen. "That's just what this building is designed to do, and at the same time it will help further advance UF's position as a national leader in research and in patient care."

The Institute on Aging's resources include the Genomics and Biomarkers Core, which will provide the infrastructure, lab space, personnel, and technologies to support 'omics-based research at the institute. These resources include tools for conducting research including genome-wide and gene expression analysis, microarray-based studies, mass spectrometry, quantitative PCR, and other approaches.

The Clinical Research Core is a resource for conducting randomized controlled trials and observational studies.

The Clinical and Translational Sciences Institute that will reside in the new building will be a multidisciplinary facility with several departments that will pursue advanced research into aging, cancer, cardiovascular disease, diabetes, and other aging-related illnesses.

The CTSI is funded with a five-year, $26 million grant from the NIH's Clinical and Translational Science Award program, and by additional commitments totaling $93 million from the UF College of Medicine and the Office of Research.

The CTSI also will include departments that will focus on biomedical informatics, biostatistics, aging and geriatric research, and epidemiology.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.